These results suggested that a high expression of EPB41L5 play a central role in the poor outcome of breast cancer patients, rather than high expression of the other EMT-related genes, including ZEB1. In this regard, it should be noted that the EPB41L5 gene is not the sole target of ZEB1. This evidence concerns the gene ZEB1 and breast carcinoma.